Diploma (LON:DPLM) PT Raised to GBX 1,400

Diploma (LON:DPLM) had its price target hoisted by Royal Bank of Canada from GBX 1,280 ($16.73) to GBX 1,400 ($18.29) in a report published on Thursday morning, Digital Look reports. They currently have a sector performer rating on the stock.

A number of other equities analysts have also recently weighed in on DPLM. Peel Hunt reissued a hold rating on shares of Diploma in a report on Monday, August 19th. JPMorgan Chase & Co. began coverage on Diploma in a report on Wednesday, May 29th. They issued an overweight rating and a GBX 1,678 ($21.93) price target for the company. Numis Securities boosted their price target on Diploma from GBX 1,420 ($18.55) to GBX 1,475 ($19.27) and gave the stock a hold rating in a report on Monday, May 13th. Finally, Barclays boosted their price target on Diploma from GBX 1,225 ($16.01) to GBX 1,300 ($16.99) and gave the stock an equal weight rating in a report on Tuesday, May 14th. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Diploma presently has an average rating of Hold and a consensus target price of GBX 1,461 ($19.09).

LON DPLM opened at GBX 1,549 ($20.24) on Thursday. Diploma has a fifty-two week low of GBX 1,144 ($14.95) and a fifty-two week high of GBX 1,654 ($21.61). The stock has a market cap of $1.75 billion and a price-to-earnings ratio of 30.37. The business has a fifty day moving average of GBX 1,465.04 and a 200-day moving average of GBX 1,478.16.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology and life sciences laboratories; electrosurgery and minimally invasive surgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Featured Article: How a Put Option Works

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.